ASCO GI 2022 Conference Coverage

 

ASCO GI 2022 Conference Coverage
K

ASCO GI 2022 Update on NIVO+ Chemo vs Chemo as 1L Treatment for Advanced GC/GEJC/EAC: Expanded Efficacy, Safety, and Subgroup Analyses From 24-month Follow-up of CheckMate 649

By ASCO GI 2022 Conference Coverage FEATURING Kohei Shitara
By ASCO GI 2022 Conference Coverage FEATURING Kohei Shitara
427 views
January 26, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Videos
12:45

ASCO GI 2022 Biliary Cancer Updates

ASCO GI 2022 Conference Coverage

K. Spencer

58 views
09:37

ASCO GI 2022 Updates in HCC

ASCO GI 2022 Conference Coverage

S. Sadeghi

97 views
05:42

ASCO GI 2022 Pembro +/- Chemo vs. Chemo Alone for PD-L1+ Advanced GC…

ASCO GI 2022 Conference Coverage

Z. Wainberg

516 views
14:06

ASCO GI 2022 on the Emerging Roles of ctDNA as a Tool in Metastatic …

ASCO GI 2022 Conference Coverage

A. Dasari

243 views
08:15

ASCO GI 2022 on a Quality-Adjusted Time Without Symptoms or Toxicity…

ASCO GI 2022 Conference Coverage

R. Sugarman

433 views
11:37

ASCO GI 2022 CRC Cases: Is It Time to De-Intensify Oxaliplatin to Im…

ASCO GI 2022 Conference Coverage

G. A. Brooks

265 views
06:54

ASCO GI 2022 Results From the PREVAIL ctDNA Study: Liquid Biopsy for…

ASCO GI 2022 Conference Coverage

J. Mencel

143 views
13:14

ASCO GI 2022 Highlights on a Multicenter Phase II Study of Neoadjuva…

ASCO GI 2022 Conference Coverage

R. Kelly

135 views
13:50
ASCO GI 2022 Conference Coverage

[PRIVATE - new ASCO version uploaded] ASCO GI 2022 Updates on the En…

Feat. V. Morris
20:21

ASCO GI 2022 Review of the Emerging Roles of ctDNA as a Tool for Ear…

ASCO GI 2022 Conference Coverage

N. Starling

370 views
05:49

ASCO GI 2022 Updates on the Dose-Escalation & Dose-Expansion Study o…

ASCO GI 2022 Conference Coverage

Y. Y. Janjigian

230 views
08:07

ASCO GI 2022 Phase I/II Study of Regorafenib and Pembrolizumab in Re…

ASCO GI 2022 Conference Coverage

A. Barzi

233 views
12:23

ASCO GI 2022 on Chemo and CRT Neoadjuvant Regimens for Locally Advan…

ASCO GI 2022 Conference Coverage

K. Kato

207 views
22:39

ASCO GI 2022 Updates on Integrating New Targeted Therapy Into Locore…

ASCO GI 2022 Conference Coverage

F. Rocha

386 views
05:54

ASCO GI 2022 on mFOLFOX6/Bev +/- Nivo for 1L Treatment of mCRC: Phas…

ASCO GI 2022 Conference Coverage

H. Lenz

489 views
14:00

ASCO GI 2022 on Triplet vs. Doublet Systemic Therapy for Advanced Re…

ASCO GI 2022 Conference Coverage

H. K. Sanoff

323 views
10:58

ASCO GI 2022 Updates on FOLFOX + nab-Paclitaxel (FOLFOX-A) in the Tr…

ASCO GI 2022 Conference Coverage

A. Benson

439 views
05:04

ASCO GI 2022 Updates on IO for Early Stage HCC

ASCO GI 2022 Conference Coverage

A. Villanueva

172 views
05:07

ASCO GI 2022 Long-Term Follow-Up of the GERCOR NIPICOL Study: One-Ye…

ASCO GI 2022 Conference Coverage

R. Cohen

440 views
08:49

ASCO GI 2022 Update on NIVO+ Chemo vs Chemo as 1L Treatment for Adva…

ASCO GI 2022 Conference Coverage

K. Shitara

427 views
07:30

ASCO GI 2022 Updates on IMbrave150 Trial: Exploratory Efficacy & Saf…

ASCO GI 2022 Conference Coverage

H. Chong Toh

94 views
04:05

ASCO GI 2022 Highlights: Host-Related Biomarkers Including Gut Micro…

ASCO GI 2022 Conference Coverage

Y. Sunakawa

191 views
09:44

ASCO GI 2022 Highlights: Clinical Utility of MSI-H Identified on Liq…

ASCO GI 2022 Conference Coverage

P. Kasi

366 views